Key result
This editorial reviews evidence that albuminuria may precede and predict the development of hypertension, suggesting a bidirectional relationship between renal abnormalities and blood pressure.
Answers are grounded in this paper and cite their sources.
This editorial emphasizes the bidirectional relationship between albuminuria and hypertension, suggesting that early renal abnormalities can predict incident hypertension.
Albuminuria has traditionally been regarded as a sign of hypertensive renal damage and a forerunner of renal and cardiovascular disease. A slight increase in urine albumin excretion, often referred to as ‘microalbuminuria’ is thought to be the consequence of long-term primary hypertension and is usually associated with other signs of cardiovascular damage such as left ventricular hypertrophy and carotid plaques or thickening [1]. Because of its powerful predictive power for cardiovascular and renal events, searching for an increase in urine albumin excretion has become a useful way to evaluate overall cardiovascular risk in clinical practice, especially in patients with hypertension or diabetes [2]. The complex relationship between albuminuria and blood pressure, however, may also be looked at from a different pathophysiological and clinical standpoint. In fact, in normotensive subjects a modest increase in albuminuria, an indicator of early endothelial abnormalities at the renal and systemic level, will eventually entail the development of arterial hypertension over time, possibly through the interaction of multiple intrarenal mechanisms. Further evidence supporting the bidirectional, intriguing relationship between kidney damage and arterial hypertension is provided by the work of Xu and co-authors published in the current issue of NDT [3]. In a cross-sectional and longitudinal study performed in a community-based cohort of elderly men in Uppsala, the authors evaluated changes in urinary albumin excretion rate (UAE), blood pressure and estimated glomerular filtration rate (eGFR) over a 6-year follow-up. Besides describing baseline associations among albuminuria, systolic, mean and pulse pressure, the authors of this elegant and accurate study report that even within the normal range, albuminuria is a predictor of a subsequent rise in blood pressure and incident hypertension, especially in patients with reduced eGFR. These data add another piece to our understanding of the complex and sometimes puzzling interplay between kidney ageing, albuminuria and hypertension. Besides the traditional thinking that renal damage may result from long-standing hypertension, this study supports a different, although not alternative pathogenetic hypothesis: subclinical renal damage may precede and predict the onset of hypertension. The pivotal, prevalent role of renal function in long-term blood pressure regulation was first demonstrated by Guyton in his seminal experimental work in the ‘70s and ‘80s [4]. At the same time, ground-breaking studies by Bianchi et al. [5] provided evidence that the hypertensive phenotype can be transferred from hypertensive mice to normotensive mice by cross-transplantation of kidneys. Complementing these experimental results, several clinical studies have since suggested that early abnormalities in kidney function in otherwise normal subjects might play a role in the pathogenesis of primary hypertension. In the Framingham cohort, over a 3-year follow-up, Wang reported that urinary albumin excretion predicted blood pressure progression in 1499 non-diabetic, non-hypertensive individuals incrementally over established risk factors and at levels well below the conventional threshold for microalbuminuria [6]. Based on their data, these authors suggested that urine albumin-to-creatinine ratio may be a useful biomarker for identifying individuals at higher risk for future hypertension development. The hypothesis that mild renal damage may precede the development of hypertension was also tested in the PREVEND study [7]. In 4635 normotensive subjects over a mean follow-up of 4.3 years, Brantsma et al. reported that baseline UAE was significantly associated with the risk of developing hypertension, with a 2.3-fold greater risk for each 10-fold increase in albumin excretion. Again, this association was independent of potential confounders, and again an interaction between UAE and GFR was found, indicating that with elevated UAE and low GFR, although still within the normal range, the risk of developing hypertension was highest. Furthermore, in the Multi-Ethnic Study of Atherosclerosis carried out on >2700 community-based, non-hypertensive, middle-aged adults, the presence of early renal dysfunction pre-dated the development of arterial hypertension, even though the reduction in eGFR turned out to be a more relevant marker of hypertension risk than urinary albumin excretion after adjustment for confounders [8]. In the Nurses' Health Study, performed on ∼2000 relatively low-risk pre- and post-menopausal women without diabetes or hypertension, Forman et al. [9] reported that higher albumin/creatinine ratios, even within the normal range, were independently associated with an increased risk of hypertension. In fact, after adjustment for several confounders, post-menopausal women within the highest albuminuria quartile showed a 70% higher risk of becoming hypertensive over an 8-year follow-up than those in the lowest quartile. Lastly, Jessani recently conducted a nested cohort study within a cluster randomized controlled trial in Pakistan on 1272 normotensive non-diabetic adults aged ≥40 years with UACR <30 mg/g [10]. Despite the relatively short follow-up period, the authors report an increased risk of incident hypertension for those in the upper quartile of albuminuria, with a significant interaction between UACR and baseline SBP, a finding which suggests greater risk for incident hypertension in patients with high normal albuminuria and lower baseline systolic blood pressure (Figure 1). Thus, even in normotensive subjects, it appears that albuminuria may signal the presence of subclinical functional or structural abnormalities, at the glomerular and/or tubular level, which may in time lead to greater renal involvement and thereby promote the development of arterial hypertension. Urine albumin excretion and incident hypertension in studies on healthy cohorts. The risk of hypertension increases along with the degree of albuminuria, even within normal range (modified from references [6, 8, 9]). Over the last few years, microalbuminuria has enjoyed growing popularity as a predictor of renal and cardiovascular morbidity and mortality in patients with hypertension, both with and without diabetes. In primary hypertension, the prevalence of microalbuminuria has been shown to vary from 5 to 30%, with higher values typically found in the presence of diabetes [11]. Increased UAE is associated with several traditional and non-traditional risk factors such as insulin resistance, lipid profile abnormalities, low-grade inflammation and smoking [11]. A positive relationship between urinary albumin excretion and blood pressure levels, especially systolic and pulse pressure, has been observed in several studies, especially when blood pressure was evaluated by means of 24-h ambulatory monitoring [11]. Microalbuminuria is a well-established marker of subclinical organ damage [12–14]. A number of studies have assessed the relationship between microalbuminuria and the presence of functional and/or structural abnormalities at the cardiac and vascular level. An independent association between albuminuria and left ventricular mass has been widely reported. In particular, increased UAE has been shown to identify a subgroup of patients with unfavourable left ventricular geometric patterns, namely concentric left ventricular hypertrophy, and those with a subclinical reduction in left ventricular function [15]. Increased UAE has also been related to extracardiac vascular changes, such as increased carotid wall thickness and carotid femoral pulse wave velocity, which are expressions of atherosclerosis and aortic stiffness, respectively. At the kidney level, higher albuminuria is associated with a mild reduction of eGFR and with increased renal vascular resistance, which reflects downstream vascular impedance, and predicts the rate of progression to end-stage renal disease in patients with chronic nephropathies [16–17] (Figure 2). An important emerging issue is the significant linear relationship between urinary albumin excretion and observed mortality [18], a phenomenon which suggests that even minimal increments of albuminuria could become clinically relevant. Albuminuria as a predictor of chronic kidney disease in primary hypertension. In adjusted analysis microalbuminuria is a stronger predictor of renal function worsening when compared with other well-known risk factors (modified from reference [17]). The pathophysiological mechanisms underlying the development of microalbuminuria are still controversial and likely multifactorial, with intrarenal hemodynamic changes secondary to increased systemic blood pressure and non-hemodynamic factors such as increased renin angiotensin aldosterone activity and generalized endothelial dysfunction certainly playing a role. Regardless of its pathogenesis, because of its ability to reflect so many clinically relevant abnormalities, in the context of hypertension, increased UAE has been taken to represent an early renal manifestation of generalized vascular dysfunction and may therefore serve as an integrated marker of renal and cardiovascular risk [19]. More recently, changes in UAE in patients under treatment have been proposed as a tool to monitor the effectiveness of treatment and changes in risk over time [20]. In some studies [21–22], although not in all [23], a reduction in albuminuria during antihypertensive treatment was associated with a reduction in cardiovascular events, regardless of blood pressure control. Further research is certainly needed in this area. In conclusion, current evidence seems to provide a more complex and fascinating picture of the relationship between blood pressure and renal abnormalities than one might expect. Besides the traditional concept that microalbuminuria and mild GFR reduction may be the result of hypertensive and atherosclerotic disease and therefore signal an unfavourable prognosis, clinical studies such as the one by Xu and Carrero clearly show that alternative sequential pathways may be encountered in clinical practice. When looking at the bidirectional relationship between hypertension and albuminuria, one cannot help but make an analogy with the well-known chicken or egg dilemma. Whether albuminuria precedes and predicts the development of hypertension or simply results from long-term exposure to it, the take-home message for the clinician here is clear. The kidney plays an undisputed role in the pathogenetic changes underlying hypertension and its complications and provides a message that can be best exploited to optimize both assessment and treatment of cardiovascular disease. None declared. (See related article by Xu et al. Urinary albumin excretion, blood pressure changes and hypertension incidence in the community: effect modification by kidney function. Nephrol Dial Transplant 2014; 29: 1538–1545.) This work was supported by grants from the Italian Ministero della Salute (Bando Giovane Ricercatore 2008, CUP G35J11000130001).
No takes yet. Share an insight, caveat, or question.
Viazzi et al. (2014) conducted an editorial in Hypertension and albuminuria. Albuminuria was evaluated. This editorial reviews evidence that albuminuria may precede and predict the development of hypertension, suggesting a bidirectional relationship between renal abnormalities and blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: